Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 18;5(4):459-462.
doi: 10.1515/almed-2024-0151. eCollection 2024 Dec.

Prueba de cabecera para la valoración de la troponina de alta sensibilidad. Experiencia en el laboratorio clínico de un hospital terciario

[Article in Spanish]
Sarra El Amrani  1 , Bastien Tossens  2 , Louisa Van Belle  2 , Judit Gonda  3 , Sherine Midoun  2 , Christophe Beauloye  4   5 , Damien Gruson  6   2   7
Affiliations

Prueba de cabecera para la valoración de la troponina de alta sensibilidad. Experiencia en el laboratorio clínico de un hospital terciario

[Article in Spanish]
Sarra El Amrani et al. Adv Lab Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicto de intereses: Los autores declaran no tener ningún conflicto de intereses.

Figures

Figura 1:
Figura 1:
Proceso de análisis de muestras mediante POCT frente al laboratorio central de Saint-Luc. Tiempo y coste de una sola prueba en el envío intra y extrahospitalario and cost al laboraotrio central, comparado con el dispositivo VTLi.
See this image and copyright information in PMC

References

    1. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–826. doi: 10.1093/eurheartj/ehad191. [Internet] [cited 2024 Jan 13] - DOI - PubMed
    1. Florkowski C, Don-Wauchope A, Gimenez N, Rodriguez-Capote K, Wils J, Zemlin A. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making? Crit Rev Clin Lab Sci. 2017;54:471–94. doi: 10.1080/10408363.2017.1399336. [Internet] [cited 2024 Jan 13] - DOI - PubMed
    1. Cullen L, Collinson PO, Giannitsis E. Point-of-care testing with high-sensitivity cardiac troponin assays: the challenges and opportunities. Emerg Med J. 2022;39:861–6. doi: 10.1136/emermed-2021-211907. [Internet] [cited 2024 Jan 13] - DOI - PMC - PubMed
    1. Apple FS, Smith SW, Greenslade JH, Sandoval Y, Parsonage W, Ranasinghe I, et al. Single high-sensitivity point-of-care whole-blood cardiac troponin i Measurement to rule out acute myocardial infarction at low risk. Circulation. 2022;146:1918–29. doi: 10.1161/circulationaha.122.061148. [Internet] [cited 2024 Jan 13] - DOI - PubMed
    1. Gunsolus IL, Schulz K, Sandoval Y, Smith SW, Lindgren B, Okeson B, et al. Diagnostic performance of a rapid, novel, whole blood, point of care high-sensitivity cardiac troponin I assay for myocardial infarction. Clin Biochem. 2022;105–106:70–4. doi: 10.1016/j.clinbiochem.2022.04.008. [Internet] [cited 2024 Jan 13] - DOI - PubMed

LinkOut - more resources